» Articles » PMID: 16955219

Evaluation of Molecular Genetic Alterations Associated with Tumor Progression in a Case of Gliomatosis Cerebri

Overview
Journal J Neurooncol
Publisher Springer
Date 2006 Sep 7
PMID 16955219
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Gliomatosis cerebri (GC) is a rare tumor characterized by widespread infiltration of the brain and spinal cord. Although GC usually demonstrates histomorphological features of a low-grade tumor, the formation of secondary highly malignant tumor regions may occur. In order to reveal molecular genetic changes associated with tumor progression in GC, we analyzed factors known to be associated with malignant progression in common astocytomas in an unusual GC case of an 18-year-old patient suffering from this disease for almost 7 years. We detected allelic losses in the Rb gene and in exon 4 of the TP53 gene in a tumor region corresponding to a glioblastoma multiforme. EGFR or MDM2 gene amplifications were absent, and no PTEN mutation or allelic loss on chromosome 10 could be detected. Moreover, compared to tumor-free brain tissue of this patient, tumor regions showed increased EGFR expression. These findings show that malignant progression in GC might be associated with the acquisition of molecular genetic changes also found in low-grade astrocytomas with progression to secondary glioblastoma. These data support the notion that GC can be regarded as a subtype of a common astrocytoma.

Citing Articles

Gliomatosis cerebri: clinical characteristics, management, and outcomes.

Chen S, Tanaka S, Giannini C, Morris J, Yan E, Buckner J J Neurooncol. 2013; 112(2):267-75.

PMID: 23341100 PMC: 3907195. DOI: 10.1007/s11060-013-1058-x.


Array-based comparative genomic hybridization and immunohistochemical studies in gliomatosis cerebri.

Min H, Kim B, Park S J Neurooncol. 2008; 90(3):259-66.

PMID: 18704270 DOI: 10.1007/s11060-008-9665-7.

References
1.
Mawrin C, von Mawrin A, Kirches E, Schneider-Stock R, Boltze C, Vorwerk C . Alterations of cell cycle regulators in gliomatosis cerebri. J Neurooncol. 2005; 72(2):115-22. DOI: 10.1007/s11060-004-2061-z. View

2.
Kros J, Zheng P, Dinjens W, Alers J . Genetic aberrations in gliomatosis cerebri support monoclonal tumorigenesis. J Neuropathol Exp Neurol. 2002; 61(9):806-14. DOI: 10.1093/jnen/61.9.806. View

3.
Henson J, Schnitker B, Correa K, Deimling A, Fassbender F, Xu H . The retinoblastoma gene is involved in malignant progression of astrocytomas. Ann Neurol. 1994; 36(5):714-21. DOI: 10.1002/ana.410360505. View

4.
Thomas M, Kalita A, Labrecque S, Pim D, Banks L, Matlashewski G . Two polymorphic variants of wild-type p53 differ biochemically and biologically. Mol Cell Biol. 1999; 19(2):1092-100. PMC: 116039. DOI: 10.1128/MCB.19.2.1092. View

5.
Schneider-Stock R, Mawrin C, Motsch C, Boltze C, Peters B, Hartig R . Retention of the arginine allele in codon 72 of the p53 gene correlates with poor apoptosis in head and neck cancer. Am J Pathol. 2004; 164(4):1233-41. PMC: 1615339. DOI: 10.1016/S0002-9440(10)63211-7. View